|
English
|
正體中文
|
简体中文
|
2833128
|
|
???header.visitor??? :
34216338
???header.onlineuser??? :
1634
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"morimoto n"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial
|
Kudo M.; Lim H.Y.; ANN-LII CHENG; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. |
| 國立成功大學 |
2020 |
Interleukin-17A/F1 from Japanese pufferfish (Takifugu rubripes) stimulates the immune response in head kidney and intestinal cells
|
Takahashi, Y.;Okamura, Y.;Morimoto, N.;Mihara, K.;Maekawa, S.;Wang, H.-C.;Aoki, T.;Kono, T.;Sakai, M.;Hikima, J.-I. |
| 國立成功大學 |
2020 |
ASC-deficiency impairs host defense against Aeromonas hydrophila infection in Japanese medaka, Oryzias latipes
|
Morimoto, N.;Okamura, Y.;Maekawa, S.;Wang, H.-C.;Aoki, T.;Kono, T.;Sakai, M.;Hikima, J.-I. |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
